PEBP1 and prostate adenocarcinoma: Neutrophils on the other hand exhibited a negative association with PEBP1/STK11 co-expression in most cancer types, particularly in gastrointestinal cancers (excluding CHOL and esophageal carcinoma (ESCA)), BRCA, CESC, PRAD, uterine corpus endometrioid carcinoma (UCEC), KIRC, lower grade glioma (LGG), lung adenocarcinoma (LUAD), MESO, HNSC, and acute myeloid leukemia (LAML).